Using an oxygen-induced retinopathy mouse model18,19, we have demonstrated that GSDMD-KO largely prevents both phases of ROP as GSDMD-KO mice had decreased retinal vasoobliteration and improved retinal vascularization. This evidence concerns the gene GSDMD and retinal disorder.